Scholarly Index
Raymond Chuen‐Chung Chang
AstraZeneca (South Korea); 23,303 total citations; 421 total publications; best world rank #279
AstraZeneca (South Korea)
23,303Total citations
421Total publications
68H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 620 | KR 9 | 98.02 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 821 | KR 6 | 95.29 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 641 | KR 16 | 95.10 |
| RNA regulation and disease | Lifetime | 764 | KR 6 | 94.55 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 872 | KR 34 | 74.01 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 681 | KR 13 | 91.05 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 279 | KR 13 | 86.33 |